These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11865091)

  • 41. Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation.
    Ellis HA; McCarthy JH; Herrington J
    J Clin Pathol; 1979 Aug; 32(8):832-44. PubMed ID: 389958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measurement of PTH fragments for assessment of renal bone disease in hemodialysis patients.
    Fehr T; Garzoni D; Staub T; Binet I; Wüthrich RP
    Kidney Blood Press Res; 2006; 29(3):175-81. PubMed ID: 16931896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-term effects of fluoride and strontium on bone formation and resorption in the mouse.
    Marie PJ; Hott M
    Metabolism; 1986 Jun; 35(6):547-51. PubMed ID: 3713515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aluminium overload of parathyroid glands in haemodialysed patients with hyperparathyroidism: effect on bone remodelling.
    Berland Y; Charbit M; Henry JF; Toga M; Cano JP; Olmer M
    Nephrol Dial Transplant; 1988; 3(4):417-22. PubMed ID: 3140127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Bone diseases in hemodialysis patients].
    Nakazawa R
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():334-8. PubMed ID: 15250319
    [No Abstract]   [Full Text] [Related]  

  • 46. Time-evolution and reversibility of strontium-induced osteomalacia in chronic renal failure rats.
    Oste L; Bervoets AR; Behets GJ; Dams G; Marijnissen RL; Geryl H; Lamberts LV; Verberckmoes SC; Van Hoof VO; De Broe ME; D'Haese PC
    Kidney Int; 2005 Mar; 67(3):920-30. PubMed ID: 15698431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A study using nondecalcified bone biopsy of the incidence and presentation forms of renal osteodystrophy].
    Lorenzo Sellares V; Torres Ramírez A; Hernández Marrero D; Rodríguez Pérez J; González Posada J; Losada Cabrera M; Maceira Cruz B; Hernández Nieto L
    Med Clin (Barc); 1991 Apr; 96(15):561-5. PubMed ID: 2051811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients.
    Faugere MC; Malluche HH
    Kidney Int; 1986 Nov; 30(5):717-22. PubMed ID: 2431192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Osteomalacia and vitamin D deficiency in hemodialyzed patients].
    Tahara H
    Clin Calcium; 2004 Sep; 14(9):42-5. PubMed ID: 15577108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluoride and dialysis osteodystrophy: results of a double-blind study.
    Oreopoulos DG; Taves DR; Rabinovich S; Meema HE; Murray T; Fenton SS; deVeber GA
    Trans Am Soc Artif Intern Organs; 1974; 20A():203-8. PubMed ID: 4615422
    [No Abstract]   [Full Text] [Related]  

  • 52. A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients.
    D'Haese PC; Spasovski GB; Sikole A; Hutchison A; Freemont TJ; Sulkova S; Swanepoel C; Pejanovic S; Djukanovic L; Balducci A; Coen G; Sulowicz W; Ferreira A; Torres A; Curic S; Popovic M; Dimkovic N; De Broe ME
    Kidney Int Suppl; 2003 Jun; (85):S73-8. PubMed ID: 12753271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients--retrospective analysis of 1429 iliac crest biopsies.
    Ballanti P; Wedard BM; Bonucci E
    Nephrol Dial Transplant; 1996 Apr; 11(4):663-7. PubMed ID: 8671855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does strict phosphorus control precipitate renal osteomalacia?
    Delmez JA; Fallon MD; Harter HR; Hruska KA; Slatopolsky E; Teitelbaum SL
    J Clin Endocrinol Metab; 1986 Apr; 62(4):747-52. PubMed ID: 3949954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
    Coen G; Ballanti P; Bonucci E; Calabria S; Centorrino M; Fassino V; Manni M; Mantella D; Mazzaferro S; Napoletano I; Sardella D; Taggi F
    Nephrol Dial Transplant; 1998 Sep; 13(9):2294-302. PubMed ID: 9761512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
    Visser WJ; Van de Vyver FL
    Clin Nephrol; 1985; 24 Suppl 1():S30-6. PubMed ID: 3915958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Osteomalacic dialysis osteodystrophy: a trial of phosphate-enriched dialysis fluid.
    Feest TG; Ward MK; Ellis HA; Aljama P; Kerr DN
    Br Med J; 1978 Jan; 1(6104):18-20. PubMed ID: 620130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenesis of osteomalacia in chronic renal failure and its relationship to vitamin D.
    Kanis JA; Hamdy NA; Cundy T
    Ann Med Interne (Paris); 1986; 137(3):193-9. PubMed ID: 3532899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.
    Fletcher S; Jones RG; Rayner HC; Harnden P; Hordon LD; Aaron JE; Oldroyd B; Brownjohn AM; Turney JH; Smith MA
    Nephron; 1997; 75(4):412-9. PubMed ID: 9127327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of haemodialysis on bone in chronic renal failure.
    Bishop MC; Woods CG; Oliver DO; Ledingham JG; Smith R; Tibbutt DA
    Br Med J; 1972 Sep; 3(5828):664-7. PubMed ID: 4650845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.